強生多款創新醫療器械進博會「首秀」

新京報

昨天

新京報訊（記者王卡拉）11月6日，強生醫療科技在第八屆進博會上宣佈，旗下ETHICON 4000作為目前JNJ" target="_blank" web="1">強生全球首款3D立體成釘腔鏡吻合器亞洲首發上市，率先服務中國患者。該產品開創式地突破傳統B型平面成釘技術，實現從二維到三維的突破。其神經介入領域的「亞洲首秀」CEREGLIDE 71遠端通路導管和「進博首秀」強易達血流導向密網支架也在同日...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2581650099"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581650099\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581650099?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-11-06 21:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581650099","market":"us","top_or_hot":-1,"title":"強生多款創新醫療器械進博會「首秀」","media":"新京報","content":"<div>\n<p>新京報訊（記者王卡拉）11月6日，強生醫療科技在第八屆進博會上宣佈，旗下ETHICON 4000作為目前JNJ\" target=\"_blank\" web=\"1\">強生全球首款3D立體成釘腔鏡吻合器亞洲首發上市，率先服務中國患者。該產品開創式地突破傳統B型平面成釘技術，實現從二維到三維的突破。其神經介入領域的「亞洲首秀」CEREGLIDE 71遠端通路導管和「進博首秀」強易達血流導向密網支架也在同日...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202511063557290650.html\">網頁鏈接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>強生多款創新醫療器械進博會「首秀」</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n強生多款創新醫療器械進博會「首秀」\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">新京報</strong><span class=\"h-time small\">2025-11-06 21:48</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>新京報訊（記者王卡拉）11月6日，強生醫療科技在第八屆進博會上宣佈，旗下ETHICON 4000作為目前JNJ\" target=\"_blank\" web=\"1\">強生全球首款3D立體成釘腔鏡吻合器亞洲首發上市，率先服務中國患者。該產品開創式地突破傳統B型平面成釘技術，實現從二維到三維的突破。其神經介入領域的「亞洲首秀」CEREGLIDE 71遠端通路導管和「進博首秀」強易達血流導向密網支架也在同日...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202511063557290650.html\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://finance.eastmoney.com/a/202511063557290650.html\">新京報</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BJJMRZ35.SGD","symbol_name":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","start_time":0,"source_url":"http://finance.eastmoney.com/a/202511063557290650.html","article_id":"2581650099","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511063557290650.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2581650099","pubTimestamp":1762436921,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"新京報訊（記者王卡拉）11月6日，強生醫療科技在第八屆進博會上宣佈，旗下ETHICON4000作為目前強生全球首款3D立體成釘腔鏡吻合器亞洲首發上市，率先服務中國患者。該產品開創式地突破傳統B型平面成釘技術，實現從二維到三維的突破。其神經介入領域的「亞洲首秀」CEREGLIDE71遠端通路導管和「進博首秀」強易達血流導向密網支架也在同日亮相。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00BDGV0183.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) INC","IE0034235303.USD":"PINEBRIDGE US RESEARCH ENHANCED CORE EQUITY \"A\" (USD) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE00BN8TJ469.HKD":"FTGF CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A\" (HKD) INC","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU2129689605.HKD":"FRANKLIN GLOBAL INCOME \"A\" (HKD) INC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU1032466523.USD":"高盛全球多资产收益组合Acc","LU2129689514.USD":"FRANKLIN GLOBAL INCOME \"A\" (USD) INC","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","BK4581":"高盛持仓","LU2129689431.USD":"FRANKLIN GLOBAL INCOME \"A\" (USD) ACC","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","BK4532":"文艺复兴科技持仓","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU1032955483.USD":"NORDEA 1 STABLE RETURN \"HB\" (USDHDG) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","09996":"沛嘉医疗-B","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4534":"瑞士信贷持仓","BK1574":"生物医药B类股","BK4533":"AQR资本管理(全球第二大对冲基金)","JNJ":"强生","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","BK4592":"伊斯兰概念","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","BK4504":"桥水持仓","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","BK4568":"美国抗疫概念","09997":"康基医疗"},"translate_title":"Johnson & Johnson's various innovative medical devices \"debut\" in China International Import Expo","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09997":1.5,"JNJ":1.5,"09996":1.5},"content_text":"新京報訊（記者王卡拉）11月6日，強生醫療科技在第八屆進博會上宣佈，旗下ETHICON 4000作為目前JNJ\" target=\"_blank\" web=\"1\">強生全球首款3D立體成釘腔鏡吻合器亞洲首發上市，率先服務中國患者。該產品開創式地突破傳統B型平面成釘技術，實現從二維到三維的突破。其神經介入領域的「亞洲首秀」CEREGLIDE 71遠端通路導管和「進博首秀」強易達血流導向密網支架也在同日亮相。　　在外科手術中，吻合組織的完整性對於患者術後恢復以及預防併發症至關重要。由於組織厚度不均、質地脆弱等因素，吻合釘可能無法牢固緊密地固定組織，進而導致血液滲漏，增加患者的術中風險。此外，如吻合釘未能完全閉合，這些「不良成釘」都可能成為組織滲漏的隱患點，增加患者感染、二次手術或住院時間延長的可能。ETHICON 4000腔鏡吻合器獨家搭載強生全球首款3D立體成釘釘倉，實現從二維到三維的結構性突破，3D立體結構能夠讓吻合釘以更全面的角度充分貼合組織，提升吻合完整性，從而降低因縫合不嚴引起的血液滲漏。同時，結合創新的預置芯片技術，ETHICON 4000腔鏡吻合器可動態調節吻合進程，有助於減少術後併發症，改善患者預後。　　「亞洲首秀」CEREGLIDE 71遠端通路導管是一款可以用於神經血管系統中的通路導管。憑藉高到位、抗打折、更耐久的出色性能，該產品最高可以到達大腦M1-M2段，輔助通路迅速建立，為卒中患者爭取寶貴的救治時間。隨着該產品的首秀，這也是強生醫療科技首次攜包括EMBOTRAP Ⅲ遠端閉合雙層網籃取栓支架、EMBOVAC顱內血栓抽吸導管、CEREBASE DA神經介入長鞘以及EMBOGUARD球囊導引導管在內的完整取栓產品線亮相進博。　　「進博首秀」強易達血流導向密網支架是一款由強生醫療科技與國內醫療創新企業暢醫達共同推出的神經介入裝置。其依託高密度網孔的血流導向原理，植入載瘤動脈後可重塑血流，促使瘤腔內血栓形成並實現閉塞。此外，該支架具有柔順性與貼壁性，能良好適應迂曲血管，為血管重建提供穩定支撐。（文章來源：新京報）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}